Review




Structured Review

Optum Inc optum ehr data
Optum Ehr Data, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optum+ehr+data/database+ehr+optum/pmc13267428-252-0-0
Average 86 stars, based on 1 article reviews
optum ehr data - by Bioz Stars, 2026-11
86/100 stars

Images

Related Articles

Clinical Proteomics:

Article Title: Abstracts of ISPEs 2025, 41st International Conference, 22-26 August 2025, Washington DC.
Article Snippet: Methods: Using the Optum Electronic Health Record (EHR) database, we identified 2 MF cohorts: (1) patients treated with RUX intended as external comparators for JAKi naïve/limited trial patients receiving MMB, and (2) patients treated with BAT intended as external comparators for JAKi- experienced patients receiving MMB. .. Comparators were identified by applying eligibility criteria from relevant clinical trials to Optum EHR data. ..

Biomarker Discovery:

Article Title: Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
Article Snippet: .. Supplementing the Optum EHR data with chart review or natural language processing of unstructured data, as well as external validation in other cohorts, is likely needed before drawing any conclusions from these data about the differences in malignancy rates between patients with and without vitiligo. ..

Article Title: Risk of Safety Events in Vitiligo Patients: A Retrospective Real-World Data Study in the US.
Article Snippet: .. Supplementing the Optum EHR data with chart review or natural language processing of unstructured data, as well as external validation in other cohorts, is likely needed before drawing any conclusions from these data about the differences in malignancy rates between patients with and without vitiligo. ..

Transplantation Assay:

Article Title: Risk of Progression and Costs of Care for Patients with Type 2 Diabetes and Chronic Kidney Disease
Article Snippet: .. Adult patients with type 2 diabetes and CKD were included if they had information on required predictors for the Klinrisk model (age, sex, baseline eGFR, and baseline UACR), no history of kidney transplantation or chronic dialysis on or before the index date (Supplementary Tables S1 and S2), at least one eGFR test after the index date, and continuous activity within the Optum EHR data during the 12 months before and after the index date (Supplementary Figure ). ..

Article Title: Risk of Progression and Costs of Care for Patients with Type 2 Diabetes and Chronic Kidney Disease.
Article Snippet: .. Adult patients with type 2 diabetes and CKD were included if they had information on required predictors for the Klinrisk model (age, sex, baseline eGFR, and baseline UACR), no history of kidney transplantation or chronic dialysis on or before the index date (Supplementary Tables S1 and S2), at least one eGFR test after the index date, and continuous activity within the Optum EHR data during the 12 months before and after the index date (Supplementary Figure S1). ..

Activity Assay:

Article Title: Risk of Progression and Costs of Care for Patients with Type 2 Diabetes and Chronic Kidney Disease
Article Snippet: .. Adult patients with type 2 diabetes and CKD were included if they had information on required predictors for the Klinrisk model (age, sex, baseline eGFR, and baseline UACR), no history of kidney transplantation or chronic dialysis on or before the index date (Supplementary Tables S1 and S2), at least one eGFR test after the index date, and continuous activity within the Optum EHR data during the 12 months before and after the index date (Supplementary Figure ). ..

Article Title: Risk of Progression and Costs of Care for Patients with Type 2 Diabetes and Chronic Kidney Disease.
Article Snippet: .. Adult patients with type 2 diabetes and CKD were included if they had information on required predictors for the Klinrisk model (age, sex, baseline eGFR, and baseline UACR), no history of kidney transplantation or chronic dialysis on or before the index date (Supplementary Tables S1 and S2), at least one eGFR test after the index date, and continuous activity within the Optum EHR data during the 12 months before and after the index date (Supplementary Figure S1). ..



Similar Products

86
Optum Inc optum ehr data
Optum Ehr Data, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optum+ehr+data/database+ehr+optum/pmc13267428-252-0-0
Average 86 stars, based on 1 article reviews
optum ehr data - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Optum Inc optum s ehr data
Optum S Ehr Data, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optum+ehr+data/database+ehr+optum/10__1002_slash_widm__70061-619-21-21
Average 86 stars, based on 1 article reviews
optum s ehr data - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Optum Inc optum ehr data source
Systematic error for the methods across different exposures, considering <t>the</t> <t>Optum</t> <t>EHR</t> data source.
Optum Ehr Data Source, supplied by Optum Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/optum+ehr+data/database+ehr+optum/med_rxiv__64898__2026__01__25__26344812-152-6-6
Average 86 stars, based on 1 article reviews
optum ehr data source - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


Systematic error for the methods across different exposures, considering the Optum EHR data source.

Journal: medRxiv

Article Title: Comparative performance of the concurrent comparator design with existing vaccine safety surveillance approaches on real-world observational health data

doi: 10.64898/2026.01.25.26344812

Figure Lengend Snippet: Systematic error for the methods across different exposures, considering the Optum EHR data source.

Article Snippet: For this, we will consider the Optum EHR data source and exposure to both the BNT126b2 and mRNA-1273 COVID-19 vaccines, all seasonal flu vaccines, H1N1pdm vaccine, Zoster vaccine, and HPV vaccine.

Techniques:

Uncalibrated Type 1 errors of methods as a function of time, across different exposures for the Optum EHR data source.

Journal: medRxiv

Article Title: Comparative performance of the concurrent comparator design with existing vaccine safety surveillance approaches on real-world observational health data

doi: 10.64898/2026.01.25.26344812

Figure Lengend Snippet: Uncalibrated Type 1 errors of methods as a function of time, across different exposures for the Optum EHR data source.

Article Snippet: For this, we will consider the Optum EHR data source and exposure to both the BNT126b2 and mRNA-1273 COVID-19 vaccines, all seasonal flu vaccines, H1N1pdm vaccine, Zoster vaccine, and HPV vaccine.

Techniques:

Calibrated type 1 errors of methods as a function of time, across different exposures for the Optum EHR data source.

Journal: medRxiv

Article Title: Comparative performance of the concurrent comparator design with existing vaccine safety surveillance approaches on real-world observational health data

doi: 10.64898/2026.01.25.26344812

Figure Lengend Snippet: Calibrated type 1 errors of methods as a function of time, across different exposures for the Optum EHR data source.

Article Snippet: For this, we will consider the Optum EHR data source and exposure to both the BNT126b2 and mRNA-1273 COVID-19 vaccines, all seasonal flu vaccines, H1N1pdm vaccine, Zoster vaccine, and HPV vaccine.

Techniques:

Power of detection for the methods as a function of time, across different exposures for the Optum EHR data source. We assume the true risk ratio = 2.

Journal: medRxiv

Article Title: Comparative performance of the concurrent comparator design with existing vaccine safety surveillance approaches on real-world observational health data

doi: 10.64898/2026.01.25.26344812

Figure Lengend Snippet: Power of detection for the methods as a function of time, across different exposures for the Optum EHR data source. We assume the true risk ratio = 2.

Article Snippet: For this, we will consider the Optum EHR data source and exposure to both the BNT126b2 and mRNA-1273 COVID-19 vaccines, all seasonal flu vaccines, H1N1pdm vaccine, Zoster vaccine, and HPV vaccine.

Techniques:

Journal: medRxiv

Article Title: Comparative performance of the concurrent comparator design with existing vaccine safety surveillance approaches on real-world observational health data

doi: 10.64898/2026.01.25.26344812

Figure Lengend Snippet:

Article Snippet: For this, we will consider the Optum EHR data source and exposure to both the BNT126b2 and mRNA-1273 COVID-19 vaccines, all seasonal flu vaccines, H1N1pdm vaccine, Zoster vaccine, and HPV vaccine.

Techniques: Produced

Systematic error for the methods, stratified across the two Covid-19 vaccines and the Optum EHR and MDCD data sources.

Journal: medRxiv

Article Title: Comparative performance of the concurrent comparator design with existing vaccine safety surveillance approaches on real-world observational health data

doi: 10.64898/2026.01.25.26344812

Figure Lengend Snippet: Systematic error for the methods, stratified across the two Covid-19 vaccines and the Optum EHR and MDCD data sources.

Article Snippet: For this, we will consider the Optum EHR data source and exposure to both the BNT126b2 and mRNA-1273 COVID-19 vaccines, all seasonal flu vaccines, H1N1pdm vaccine, Zoster vaccine, and HPV vaccine.

Techniques: Vaccines

Calibrated type 1 error for the methods as a function of time, stratified across the two Covid-19 vaccine exposures and the Optum EHR and MDCD data sources.

Journal: medRxiv

Article Title: Comparative performance of the concurrent comparator design with existing vaccine safety surveillance approaches on real-world observational health data

doi: 10.64898/2026.01.25.26344812

Figure Lengend Snippet: Calibrated type 1 error for the methods as a function of time, stratified across the two Covid-19 vaccine exposures and the Optum EHR and MDCD data sources.

Article Snippet: For this, we will consider the Optum EHR data source and exposure to both the BNT126b2 and mRNA-1273 COVID-19 vaccines, all seasonal flu vaccines, H1N1pdm vaccine, Zoster vaccine, and HPV vaccine.

Techniques:

Calibrated power of detection for the methods as a function of time, stratified across the two Covid-19 vaccine exposures and the Optum EHR and MDCD data sources.

Journal: medRxiv

Article Title: Comparative performance of the concurrent comparator design with existing vaccine safety surveillance approaches on real-world observational health data

doi: 10.64898/2026.01.25.26344812

Figure Lengend Snippet: Calibrated power of detection for the methods as a function of time, stratified across the two Covid-19 vaccine exposures and the Optum EHR and MDCD data sources.

Article Snippet: For this, we will consider the Optum EHR data source and exposure to both the BNT126b2 and mRNA-1273 COVID-19 vaccines, all seasonal flu vaccines, H1N1pdm vaccine, Zoster vaccine, and HPV vaccine.

Techniques: